* Codes: lung and bronchus 162. 2-162.5, 162.8-162.9; colon and rectum 153, 154.0-154.1, 159. Death rates for prostate cancer were more than twice as high for blacks than for whites (Table 1) . Rates were lowest among APIs. Death rates decreased for men of each race/ethnicity except AI/ANs (Table 1, Figure 1 ). The declines in death rates for whites (2.8% per year) and APIs (3.4% per year) were approximately twice the decreases for blacks, Hispanics, and AI/ANs.
In 1998, 53% of all cancer-related deaths in the United States were associated with four sites: lung/bronchus, colon/ rectum, prostate, and female breast (1 ) . Cancer-related death does not affect racial/ethnic populations similarly. In 1996, the National Cancer Institute (NCI) published cancer incidence and death rates during 1988-1992 in 10 categories of race/ethnicity (2 ) . To examine trends during 1990-1998 in annual death rates for the four major cancers by sex and race/ ethnicity (i.e., blacks, whites, Hispanics, American Indians/ Alaska Natives [AI/ANs], and Asians/Pacific Islanders [APIs]), CDC analyzed data from the National Center for Health Statistics' National Vital Statistics System (3). This report summarizes the results of that analysis, which indicated that, except for lung cancer in women and lung, colorectal, and breast cancer in AI/ANs, trends in death rates from these cancers have generally declined. But the rates remained high for blacks, have not decreased equally among all populations, and have increased in certain instances. Continuing research and prevention efforts are needed to reach high-risk and underserved populations and to understand the reasons for differences in cancer mortality among racial/ethnic populations.
In each state, attending physicians report and file causes of death on death certificates, which then are consolidated into the National Vital Statistics System. For this analysis, the International Classification of Diseases, Ninth Revision, (ICD-9) codes* for cause of death from these cancers and NCI software were used to compute death rates as the number of deaths per 100,000 population, age-adjusted to the 1970 U.S. population by using 5-year age intervals. Deaths and death rates were presented for 1990-1998 for whites, blacks, Hispanics, AI/ANs, and APIs. To test for significant trends in death rates during 1990-1998, linear regression was used to estimate the annual percentage change for this period.
Data from 1998 indicated that death rates for lung and bronchus cancer were higher for blacks and whites than for other races/ethnicities (Table 1) . Death rates for black men were higher than for white men. Among men, death rates from lung and bronchus cancer decreased 1% to 2% per year for each race/ethnicity except AI/ANs. Among AI/ANs, death rates increased 1.7% per year among men and 2.9% per year among women. Death rates also increased for white and black women.
For 1998, death rates for colorectal cancer for each race/ ethnicity were approximately 40% higher among men than women (Table 1) . Blacks had the highest death rate for colorectal cancer, followed by whites. Death rates for colorectal cancer decreased 2.2% per year for white men and 1.8% per year for white women. Declines in death rates among black men and women were approximately 50% less than that for whites. Death rates for colorectal cancer increased 4.5% per year for AI/AN men, although the increase was not significant because of year-to-year variations in rates.
Editorial Note: The findings in this report indicate that death rates have declined for lung and bronchus, colorectal, prostate, and female breast cancers among most racial/ethnic populations; however, death rates remained high for certain cancers among blacks and are generally increasing among AI/ANs. Trends in cancer death rates might reflect changes in cancer risk behaviors, new screening modalities, and the development and use of new and more effective treatments (1) .
Lung and bronchus cancer was the most important cause of cancer mortality in the 1990s, accounting for approximately 28% of all cancer-related deaths (1) . Approximately 90% of these deaths have been attributed to smoking (4, 5) . Changes in death rates reflect substantial decreases in smoking during 1965-1985 among men (51.9% to 32.6%) and smaller decreases among women (33.9% to 27.9%) (5) . Increases in death rates for AI/ANs probably reflect increases in smoking rates. AI/ANs have among the highest smoking rates in the United States (6) .
Incidence of colorectal cancer among whites has been decreasing since approximately 1985 and has remained virtually unchanged for blacks, AI/ANs, APIs, and Hispanics. In the 1990s, decreases in death rates might relate to the increased use of chemotherapy and to screening and early detection (7 ) . During 1987 During -1998 , the percentage of persons aged >50 years who ever had sigmoidoscopy/proctoscopy increased from 24% to 38%. During 1992-1998, the percentage of persons in this age group who had had fecal occult blood testing within a 2-year period increased from 30% to 33% (7) .
Prostate cancer is second to lung cancer as a cause of cancer-related death among men. The gradual decreases in death rates for all the reported races/ethnicities during the study period might reflect aggressive treatment of advanced cancer and use of serum prostate-specific antigen (PSA) testing (1 ). However, the effectiveness of PSA screening and earlystage treatment in reducing mortality is unknown. Breast cancer accounts for the second largest proportion of cancer-related deaths among women (1) . The recent increase in the incidence of breast cancer probably reflects greater use of screening and early detection because the increase has occurred mostly among women diagnosed with early-stage disease (1) . By 1997, the percentage of women aged >40 years who reported having had a mammogram during the preceding 2 years was 72.9% for blacks, 72.5% for APIs, 71.4% for whites, 67% for Hispanics, and 59.9% for AI/ ANs (8).
The findings in this report are subject to at least two limitations. First, the reporting of race/ethnicity to the U.S. Bureau of the Census and on death certificates usually is reliable for blacks and whites (9); however, underreporting for other races/ ethnicities can understate death rates from 2% among Hispanics to 21% among AI/ANs. Second, because this study was a description of national trends and not an evaluation of cancer intervention studies, the findings should be interpreted with caution.
One of the goals of the national health objectives for 2010 is to eliminate health disparities among racial/ethnic populations. CDC supports several initiatives that address the four major cancers: national tobacco-control efforts; Screen for Life, a multimedia campaign promoting prevention and early detection of colorectal cancer; and Racial and Ethnic Approaches to Community Health (REACH 2010). CDC also funds research on the high death rates from prostate cancer among blacks and the National Breast and Cervical Cancer Early Detection Program, which provides screening to underserved women. Additional information about CDC's cancer prevention and control programs is available at http:// www.cdc.gov/tobacco; http://www.cdc.gov/cancer; and http:// www.cdc.gov/cancer/minorityawareness.htm.
Differences in cancer death rates result from a combination of factors such as behaviors (e.g. smoking and nutrition); access to preventive, diagnostic, therapeutic, and screening services; and aggressiveness of treatment. If these factors were modified, more than half of the cancer deaths could be prevented and most racial/ethnic disparities in cancer death rates could be eliminated. 
Immunization Registry Use and Progress -United States, 2001
Immunization registries are confidential, population-based, computerized information systems that collect vaccination data about all children within a geographic area (1). Registries are key tools used to increase and sustain high vaccination coverage by providing complete and accurate information 0%-50%* 51%-100% Not Population-Based Community-Based Only † § ¶ Data from the 32 grantees operating population-based registries indicated that approximately 49% of the estimated 11.4 million children aged <6 years, based on the U.S. Census, in these catchment areas had >2 vaccinations recorded in the registry. The 32 grantees also reported that an average of 56% of public vaccination provider sites and 41% of private provider sites in their catchment areas participated in the registry during the 6 months preceding completion of the CY 2000 IRAR. All 51 grantees were working to meet key elements of the 13 functional standards established for immunization registries (Table 1) . Although no registry has met all key elements of all standards, 14 of the 51 grantees have met all key elements of >11 of the standards (3). Editorial Note: In 2000, the Institute of Medicine noted, "with the increasing importance of population-based approaches to health system planning and evaluation, immunization registries offer one of the most useful instruments for assessing population-specific effectiveness of health and medical care programs" (4) . Projects use their registries for program decision support as exemplified by San Antonio's use of registry data to examine the implementation of new vaccines through the Vaccines for Children (VFC) entitlement program. San Antonio's data demonstrated that, although non-VFC providers began using heptavalent pneumococcal conjugate vaccine (PCV7) soon after licensure, delay in VFC reimbursement might have caused slower PCV7 uptake among VFC-eligible children (5). Other projects have used their registry data to measure reminder/recall system effectiveness (6), identify sources of delayed immunizations (7), and track the implementation of immunization schedule changes (8).
Oregon registry data were used to assess the impact on hepatitis B (HepB) vaccine administration after issuance of the Joint Statement of the American Academy of Pediatrics (AAP) and the U.S. Public Health Service (USPHS) (9) about using thimerosal as a vaccine preservative. Their joint statement recommended reducing infant exposure to thimerosal; specific recommendations were made to postpone the first HepB vaccine dose until age 2-6 months for infants born to hepatitis B surface antigen-negative mothers. Oregon's registry data (which include 88% of the state's population of children aged <6 years) indicated that the average proportion of children participating in the registry per week who were administered HepB vaccine <5 days after birth decreased 93% during the 6 weeks after the report's release ( Figure 2 ). On the basis of these data, Oregon officials contacted health plans, healthcare providers, and local health departments to ensure that the report's recommendations were being followed (i.e., that the first dose of HepB be delayed only for infants born to hepatitis B surface antigen-negative mothers and that providers return to previous infant HepB vaccination practices after a thimerosal-free alternative became available). Continued monitoring of registry data indicated that, despite the availability of thimerosal-free vaccine in August 1999, by the end of 2000, administration rates had reached only 88% of prereport levels for HepB vaccination (8). These data assist education efforts for providers who have not reinstated HepB vaccine recommendations.
CDC recently identified for grantees eight core program attributes in the Immunizations Program Operations Manual released in 2001: population assessment, surveillance, consumer information, service delivery, provider quality assurance, vaccine management, registry development, and program management (10). CY 2000 IRAR data indicate that certain grantees might have the capacity to use registry data to support these program attributes. For example, 42 grantees use registry data to determine vaccine coverage among different segments of the population, and 32 grantees track VFC participant eligibility by using their registries. CDC is collecting data to monitor projects' use of registries and registry data to support each of these program attributes beginning with the CY 2001 IRAR.
The findings in this report are subject to at least three limitations. First, because the annual report relied on self-reported information, bias in reporting could have occurred. However, on-site verification through record reviews and observation of registry operations during the 20 site visits performed in 2000 indicated that 98.3% of the answers provided by those sites in response to the previous year's annual report were accurate. Second, because only information from these 51 immunization grantees was included in the analyses, any immunization registry development performed by other entities (e.g., city immunization grantees, hospitals, local health departments, and managed care plans) would not be included in these findings. This could result in an underestimation of the degree of registry development in the United States. Finally, the CY 2000 IRAR did not collect information about the completeness or accuracy of immunization data recorded in a registry. Tools are under development at CDC to assist with registry data quality assessment.
Immunization registries continue to develop to improve vaccination coverage and reach the 2010 national health objective of 95% participation for children aged <6 years. Additional information about immunization registries is available from CDC at http://www.cdc.gov/nip/registry; by telephone at 800-799-7062; or by e-mail at siisclear@cdc.gov. 
Week and Year

Emergency Medical System Responses to Suicide-Related Calls -Maine, November 1999-October 2000
Suicidal acts are morbid and potentially lethal events that are risks for subsequent completed suicide and possibly other health problems (e.g., substance abuse and depression) (1, 2) . Suicidal behavior also can have negative consequences on family members, friends, and caregivers (3). In 1996, the cost of health care and lost wages for suicide attempts in Maine was approximately $115 million (4) . In 1999, a total of 1,079 persons were hospitalized in Maine for self-injurious behavior. Although Maine has no injury-related surveillance systems, the Maine Bureau of Health (MBOH) assessed the use of Emergency Medical Service (EMS) response data to estimate incidence of EMS responses to suicide-related calls in Maine and to summarize the distribution of these responses by patient and event characteristics. This report describes EMS suicide-related responses during November 1999-October 2000 and indicates that EMS data would be a useful component of an integrated statewide suicidal behavior surveillance system.
Maine EMS responders complete a run report form (RRF) for each emergency assistance call. RRF contains a check box titled "concern suicide," which is selected "for patients who have, relevant to this call/run, expressed or displayed any suicidal tendencies or attempts." For any RRF on which "concern suicide" is selected, personal identifiers are removed and the form is sent to the MBOH Injury Prevention Program (MIPP). RRF has defined fields for sex, age, date of birth, incident date, incident location, incident site*, town of residence, insurance payor, and EMS service number. EMS responders can provide additional information in a free text field, from which MIPP extracts data on method of attempt or threat and circumstances surrounding the event.
Inclusion criteria for this analysis were 1) "concern suicide" box checked on the RRF, 2) confirmed Maine residency, 3) aged >10 years † , and 4) presence of a unique RRF number. If RRFs were duplicated, only one was counted as a case. Of the 2,152 RRFs received during November 1999-October 2000, a total of 2,036 (95%) were eligible for inclusion in the analysis, of which 967 (47.5%) were made for the intra-or interinstitutional transportation of suicidal residents from nursing homes, psychiatric, correctional, or medical facilities § . Data were evaluated separately for all responses and for the 1,069 noninstitutional (NI) responses. All age-adjusted rates were standardized to the 2000 U.S. standard population and included both completed suicides and nonlethal attempts.
For all calls, age-adjusted EMS response rates to "concern suicide" in Maine were 179.2 per 100,000 females and 142.3 per 100,000 for males. For females, age-specific rates were highest among those aged 15-19 years (384.8); for males, rates were highest for those aged 20-24 year (258.1). Because geographic and event data are limited for the institutionalized subgroup, the remainder of the descriptive analysis was limited to the NI cases.
* Location is town and state of the incident; site is the type of location (e.g., home, office, school, or highway). † Age cutoff was set at age 10 years because only three RRFs were submitted for children aged <10 years, and suicidal behavior in this age group is sufficiently different than the 10-14 year age group to make comparing them problematic. § The current data entry system does not allow for distinctions between persons being transported from nursing homes and residential facilities versus from correctional facilities. .0-110.4) . Age-specific rates were statistically similar for females aged 20-34 years and >55 years and for males aged 25-54 years. All other age-specific rate differences were statistically significant (p < 0.05). In comparison, suicide completion rates (derived from medical examiner data) were uniform across all female age groups (range: 0-10.7) and were highest among males aged >45 years (range: 25.0-34.8) (Figure 1) .
Among the 1,069 NI responses, 761 (72.0%) were to the residence of the attempter. EMS calls were most frequent in the summer (27.1%) and least frequent in the winter and spring (23.5% and 23.3%, respectively).
Among the 963 (90.1%) NI cases for which method was documented, overdose (29.9%), "suicidal ideation only" (27.0%), and laceration (17.7%) were the most commonly documented methods. Attempts with firearms comprised 3.7%.
The case-fatality ratio for EMS calls was 3.8% (1.3% for females and 6.9% for males). Case-fatality ratios were highest among males aged >65 years (15.2%). Method employed also was related to fatality ratios, even in the minority of completions ¶ receiving EMS response. Of the 36 EMS responses to firearm-related suicidal behavior, 21 (58.3%) were lethal by the time of RRF completion. Compared with drug overdoses (1.0% lethal), attempts by firearm and hanging receiving EMS response were 58 and 60 times more lethal, respectively.
Of the 1,069 events, circumstance was reported for 636 (59.5%); a total of 695 circumstances were reported. The most commonly reported circumstances were drug/substance abuse at the time of the incident (220 Editorial Note: Among all states, Maine ranks 14th in rate of suicide deaths (13.4 per 100,000 population); this rate is 25% higher than the national rate (5). Despite the magnitude of the problem, no surveillance system exists in Maine to monitor suicidal behavior. The findings in this report indicate that EMS NI responses to suicide-related calls in Maine identified characteristics similar to those in community-and population-based studies of nonlethal suicidal behaviors (6-8) and might be an important component of a suicide surveillance system. Virtually all (99%) EMS response data in Maine from state-, municipal-, volunteer-, and fire-department-based and private services are compiled in a centralized database. In addition, Maine is developing an electronic reporting form and a mobile data input system for use across all 141 EMS services.
The findings in this report are similar to other populationand community-based studies of the distribution of injuries associated with nonfatal suicidal behavior. Findings were similar for age, sex, location, method, and circumstances of suicide-related injuries. Other findings, such as seasonality of the suicidal act and a description of the institutionalized population, might be important for prevention efforts and require further analysis.
Although this approach demonstrates the value of existing EMS response data for injury surveillance, the findings are subject to several limitations. First, no systematic mechanism exists to ensure that only one RRF is filed for each event or for systematically identifying repeat attempters. Second, the dataset contains only those events for which an RRF is completed. Many persons who contemplate or attempt suicide will not seek assistance and no surveillance instrument, except possibly population-based surveys, will detect these events (1) . Despite the lack of prevalence data, demographic and event characteristic profiles parallel those previously documented (1,6-9). Moreover, incidence estimates (i.e., estimates of the total societal burden of attempts) may be most valuable in determining health services needs. Third, because unique record linkages with other health service data systems cannot currently be made, the sensitivity of EMS data, even to those who will eventually visit the emergency department or be admitted to the hospital, is unknown. Finally, this analysis includes data for only 12 months; as a result, the sample size is relatively small, which precludes description of temporal trends over several years. However, analysis at the early stage of development provides opportunities for improving the data collection system and preparing for its use in public health surveillance.
Prevention of suicidal behaviors and attempts might preclude more life-threatening health problems (1) . EMS data provide information about suicidal acts and might be useful in early prevention efforts. In addition, EMS data provide event detail unavailable in other health information systems. Data about the circumstances surrounding violent injuries are critical to understand attempt risk and to develop ageand sex-specific prevention strategies. Although refinements are needed, EMS data, together with medical examiner, hospital discharge, and emergency department data, would be a useful component of an integrated statewide suicidal behavior surveillance system (10). 6 
Notice to Readers
Evaluation of Postexposure Antibiotic Prophylaxis to Prevent Anthrax
In response to the recent bioterrorist attacks associated with intentional release of Bacillus anthracis, approximately 10,000 persons potentially exposed to anthrax in Connecticut, Florida, New Jersey, New York City, and Washington, D.C., were recommended to take at least 60 days of postexposure antibiotic prophylaxis. Surveillance for adverse events and adherence to antibiotics has been conducted through surveillance and cross-sectional studies. CDC is evaluating the program to distribute antimicrobial agents and assessing adverse events and adherence. The objectives of this evaluation are to assess the provision of antimicrobial agents and educational materials to affected persons, to determine adverse events associated with the antimicrobial agents, and to characterize adherence to the recommended regimen. The information from this evaluation will be critical to CDC's effort to improve the technical assistance and supplies needed with future anthrax postexposure prophylaxis campaigns and to comply with Food and Drug Administration regulations for monitoring for adverse events.
CDC has contracted RTI International to conduct brief telephone interviews of all persons for whom postexposure antibiotic prophylaxis was recommended. Interviews are scheduled to begin in late January 2002 and will continue for approximately 8 weeks. Additional information about the program evaluation is available from CDC, telephone 404-639-3158. - PACIFIC  1  7  --71  95  15  58  2  2  Wash. - - 
